Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Revenue (2018 - 2025)

Historic Revenue for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $16.2 million.

  • Dna X's Revenue rose 793.5% to $16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.1 million, marking a year-over-year increase of 416.78%. This contributed to the annual value of $58.3 million for FY2024, which is 3773.71% down from last year.
  • According to the latest figures from Q3 2025, Dna X's Revenue is $16.2 million, which was up 793.5% from $11.2 million recorded in Q2 2025.
  • In the past 5 years, Dna X's Revenue registered a high of $27.6 million during Q3 2023, and its lowest value of $11.2 million during Q2 2025.
  • Over the past 5 years, Dna X's median Revenue value was $15.0 million (recorded in 2024), while the average stood at $16.9 million.
  • As far as peak fluctuations go, Dna X's Revenue soared by 12446.68% in 2023, and later plummeted by 5708.59% in 2024.
  • Over the past 5 years, Dna X's Revenue (Quarter) stood at $15.9 million in 2021, then surged by 51.39% to $24.1 million in 2022, then tumbled by 44.32% to $13.4 million in 2023, then grew by 11.57% to $15.0 million in 2024, then rose by 8.21% to $16.2 million in 2025.
  • Its Revenue stands at $16.2 million for Q3 2025, versus $11.2 million for Q2 2025 and $16.7 million for Q1 2025.